Canada Herceptin Market Size, Share, Analysis, Forecasts To 2033
Herceptin is a targeted therapy drug used primarily to treat breast cancer and gastric cancer that overexpress the HER2 protein, a key driver in the development of these cancers. In Canada, Herceptin is widely used in the oncology sector, particularly for patients with HER2-positive breast cancer, both in early-stage and metastatic settings.